Bias associated with failing to incorporate dependence on event history in Markov modelsTanya G K Bentley
RAND Corporation, Santa Monica, CA, USA
Med Decis Making 30:651-60. 2010
..This analysis assessed the tradeoffs between model bias and complexity when evaluating risks of recurrent events in Markov models...
Race and gender associations between obesity and nine health-related quality-of-life measuresTanya G K Bentley
Partnership for Health Analytic Research, LLC, 280 South Beverly Drive 404, Beverly Hills, CA 90212, USA
Qual Life Res 20:665-74. 2011
..To assess how health-related quality of life (HRQoL) varies by body mass index (BMI) category among gender and racial subgroups using nine HRQoL measures...
Methods for improving efficiency in quality measurement: the example of pain screeningT G K Bentley
Partnership for Health Analytic Research, LLC, Beverly Hills, CA 90212, USA
Int J Qual Health Care 23:657-63. 2011
..Collecting unnecessary data when assessing quality of care wastes valuable resources. We evaluated three approaches for estimating quality-measure adherence and determined minimum visit data required to achieve accurate estimates...
Using administrative claims data to estimate virologic failure rates among human immunodeficiency virus-infected patients with antiretroviral regimen switchesMichael S Broder
Partnership for Health Analytic Research, Beverly Hills, California 90212, USA
Med Decis Making 32:118-31. 2012
..To develop and validate a claims signature model that estimates proportions of HIV-infected patients in administrative claims databases who switched combination antiretroviral therapy (cART) regimens because of virologic failure...
Cost-effectiveness of 21-gene assay in node-positive, early-stage breast cancerBurton F Vanderlaan
Partnership for Health Analytic Research, Beverly Hills, CA 90212, USA
Am J Manag Care 17:455-64. 2011
..To assess impact on health outcomes and healthcare expenditures of adopting a 21-gene assay for women with early-stage, minimally node-positive, estrogen receptor-positive (N (1-3)/ER) HER2-negative breast cancer...
Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United StatesMichael S Broder
Partnership for Health Analytic Research, Beverly Hills, CA, USA
J Med Econ 14:167-78. 2011
..To evaluate lifetime cost effectiveness of atazanavir-ritonavir (ATV + r) versus lopinavir-ritonavir (LPV/r), both with tenofovir-emtricitabine, in US HIV-infected patients initiating first-line antiretroviral therapy...